VANCOUVER, Feb. 22, 2019 /CNW/ - Dexcom, Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), today announced that the company has received Health Canada approval for its next ...
Huons announced on the 29th that it has decided to expand the free support of transmitters for the continuous glucose monitor (CGM) 'Dexcom G6' for diabetes patients. The transmitter is a device that ...
Dexcom G6 was the first Continuous Glucose Monitoring (CGM) System to be officially listed by the NIHB Drug Benefit program. BURNABY, British Columbia — Dexcom, Inc. (NASDAQ: DXCM), the global leader ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback